By Ellen Capon (Drug Target Review)2023-12-20T14:00:33
The first multi-chamber cardioids derived from hiPSCs have enabled scientists to investigate heart development and defects.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2025-06-11T14:00:00
Sponsored by Eurofins Discovery
2025-09-24T14:00:00
Sponsored by Eurofins Discovery
2024-01-10T08:56:17
Sponsored by Leica Microsystems
2023-02-23T14:02:18
Sponsored by bit.bio
2024-01-09T10:09:08
Sponsored by Sartorius iQue®
2024-02-08T11:07:39
Sponsored by Samplix ApS
Site powered by Webvision Cloud